Equities

Sabra Health Care REIT Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Sabra Health Care REIT Inc

Actions
  • Price (MXN)338.27
  • Today's Change19.74 / 6.20%
  • Shares traded--
  • 1 Year change--
  • Beta0.6384
Data delayed at least 20 minutes, as of Mar 14 2025 11:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Sabra Health Care REIT Inc (SBRA*:MEX) closed at 338.27, 0.00% above its 52-week low of 338.27, set on Mar 14, 2025.
52-week range
Today
338.27Mar 14 2025342.81Mar 14 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open--
High338.27
Low338.27
Bid--
Offer--
Previous close318.53
Average volume--
Shares outstanding249.35m
Free float246.10m
P/E (TTM)26.38
Market cap4.78bn USD
EPS (TTM)0.727
USD
Annual div (ADY)21.01
MXN
Annual div yield (ADY)--
Div ex-dateNov 18 2025
Div pay-dateNov 28 2025
Next div ex-dateFeb 13 2026
Next div pay-dateFeb 27 2026
Data delayed at least 20 minutes, as of Mar 14 2025 11:30 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.